XBiotech Inc. (NASDAQ: XBIT)
$6.25
+0.0300 ( +0.48% ) 115.0K
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
Market Data
Open
$6.25
Previous close
$6.22
Volume
115.0K
Market cap
$191.58M
Day range
$5.99 - $6.55
52 week range
$3.51 - $9.96
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 71 | Mar 15, 2024 |
4 | Insider transactions | 2 | Jan 05, 2024 |
8-k | 8K-related | 14 | Jan 04, 2024 |
10-q | Quarterly Reports | 46 | Nov 09, 2023 |
10-q | Quarterly Reports | 44 | Aug 11, 2023 |